These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 17234760)
1. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
3. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Drivdahl R; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Plymate SR Oncogene; 2004 Jun; 23(26):4584-93. PubMed ID: 15077158 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells. He D; Falany CN Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250 [TBL] [Abstract][Full Text] [Related]
5. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687 [TBL] [Abstract][Full Text] [Related]
6. Androgen deprivation increases p300 expression in prostate cancer cells. Heemers HV; Sebo TJ; Debes JD; Regan KM; Raclaw KA; Murphy LM; Hobisch A; Culig Z; Tindall DJ Cancer Res; 2007 Apr; 67(7):3422-30. PubMed ID: 17409453 [TBL] [Abstract][Full Text] [Related]
7. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling. Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth. Mazor M; Kawano Y; Zhu H; Waxman J; Kypta RM Oncogene; 2004 Oct; 23(47):7882-92. PubMed ID: 15361837 [TBL] [Abstract][Full Text] [Related]
9. A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells. Yang X; Chen MW; Terry S; Vacherot F; Chopin DK; Bemis DL; Kitajewski J; Benson MC; Guo Y; Buttyan R Cancer Res; 2005 Jun; 65(12):5263-71. PubMed ID: 15958572 [TBL] [Abstract][Full Text] [Related]
10. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446 [TBL] [Abstract][Full Text] [Related]
11. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Agoulnik IU; Vaid A; Bingman WE; Erdeme H; Frolov A; Smith CL; Ayala G; Ittmann MM; Weigel NL Cancer Res; 2005 Sep; 65(17):7959-67. PubMed ID: 16140968 [TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer. Das S; Roth CP; Wasson LM; Vishwanatha JK Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor. Zhu H; Mazor M; Kawano Y; Walker MM; Leung HY; Armstrong K; Waxman J; Kypta RM Cancer Res; 2004 Nov; 64(21):7918-26. PubMed ID: 15520198 [TBL] [Abstract][Full Text] [Related]
14. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
15. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro. Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304 [TBL] [Abstract][Full Text] [Related]
16. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977 [TBL] [Abstract][Full Text] [Related]
17. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526 [TBL] [Abstract][Full Text] [Related]
18. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890 [TBL] [Abstract][Full Text] [Related]
19. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q; Titus MA; Fung KM; Lin HK J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593 [TBL] [Abstract][Full Text] [Related]
20. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]